Gastrointestinal cancer (GIC) has high morbidity and mortality as one of the main causes of
cancer death. Preoperative risk stratification is critical to guide patient management, but …

Background Several prognostic scores were designed in order to estimate the risk of
postoperative adverse events. None of them includes a component directly associated to the …

Background There is a consensus that neoadjuvant therapy is an essential component of
treatment for resectable advanced esophageal cancer. The aim of this study was to evaluate …

Purpose To explore and evaluate the potential value of dynamic contrast-enhanced (DCE)
magnetic resonance imaging (MRI) for the prediction of pathologic response to neoadjuvant …

Background Pathological response is a critical factor in predicting long-term survival of
patients with esophageal cancer after preoperative therapy. However, the validity of using …

Purpose: Esophageal cancer is a deadly malignancy with a 5-year survival rate of only 5%
to 20%, which has remained unchanged for decades. Esophageal cancer possesses a high …

Background and purpose With currently available techniques, the prediction of pathologic
complete response after neoadjuvant chemoradiotherapy is insufficient. The tumor-stroma …

Purpose Accurate assessment of residual disease of tumor and lymph nodes after
neoadjuvant immunochemotherapy is crucial in the active surveillance for patients with …

Background Neoadjuvant radiochemotherapy (nRCT) followed by surgery has become the
gold standard treatment in patients with locally advanced esophageal cancer. The …

Objective: The aim of this study is to assess CT-PET and endoscopic assessment
postneoadjuvant chemoradiotherapy (nCRT) in predicting complete pathologic response …